Leukemia and Lymphoma Society Discovery Grants Program

  •  Grant
  •  03-Mar-2025
  •   Germany
  • $$  $750,000.00

Are you an independent investigator with a passion for blood cancer research? Apply now for the Leukemia and Lymphoma Society’s Discovery Grants Program! With $750,000 in funding, this grant supports research projects that can transform blood cancer treatments.

Applicants for the Leukemia and Lymphoma Society Discovery Grants Program must hold a PhD, MD, DVM, or equivalent degree and be independent investigators affiliated with a non-profit institution. Eligibility requires that the Principal Investigator (PI) has more than three years of experience in an independent faculty position and a proven track record in blood cancer research.The Leukemia & Lymphoma Society (LLS) is a prominent nonprofit organization dedicated to combating blood cancers, including leukemia, lymphoma, Hodgkin’s disease, and myeloma. Founded in 1949, LLS is at the forefront of the fight against blood cancers, funding cutting-edge research, providing support services to patients and families, and advocating for policy changes that improve patient access to care. Through its extensive research funding programs, LLS aims to discover new treatments and ultimately find cures for blood cancers.

Eligibility Criteria

  • Eligible Countries: All nationalities are eligible to apply.
  • Acceptable Course or Subjects: The scholarship will be awarded for research focused on blood cancer properties and vulnerabilities, with the aim of advancing treatments for blood cancers.
  • Admissible Criteria: To be eligible, applicants must meet all the following criteria:
  • Degree: Applicants must hold a PhD, MD, DVM, or an equivalent degree.
  • Institutional Affiliation: Must be independent investigators affiliated with a non-profit institution at the time funding commences and for the duration of the award. Applications from non-academic facilities are not eligible.
  • Principal Investigator (PI):
    • Must be an independent investigator with more than 3 years in an independent faculty appointment.
    • Must have a significant track record in malignant hematology and/or blood cancer research, or have a Co-Principal Investigator who does.
  • Co-Principal Investigator (Co-PI):
    • Must be an established, independent investigator with more than 3 years in an independent faculty appointment.
    • Only one Co-PI is allowed, and they must contribute significantly to the research aims.

Offered Benefits

  • The program offers a total award of $750,000.00, allocated at $250,000 per year for three years.
  • Indirect costs are limited to 10% of the total award value.

Application Process

Application Process:

  • Pre-Application (LOI): Submit the Letter of Intent by September 18, 2024, via the LLS Research Portal.
  • Full Application: If invited, submit the full application by March 3, 2025, via the LLS Research Portal.

For detailed submission guidelines and deadlines, applicants are advised to consult their institutional research office and the LLS Research Portal.

Postdocs, students, and trainees: For fellowships and externally-sponsored research training awards or opportunities, you must complete the  Research Funding Application Approval (RFAA) Trainee PDF form, and submit it, along with a complete copy of the application, to Research Services at  . Trainees should not use RMS at this time.

Apply Here
If you think this scholarship can be helpful to somebody else, please share:

Subscribe for Scholarship Updates

Get a weekly email that thousands of students use to get the latest scholarships and grants.


** Scholarships.plus will not share your details without your permission.

Like our website? Follow us on Facebook

More Suggestions: